May 13, 2025 Bill: SB2308 Caption: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and the administration of that treatment. Vote Purpose: View Vote at Source: View Vote View Bill at Source: View Bill |
RV#2324: Yea 138 (R 78, D 60) - Nay 2 (R 2, D 0) Yea - Nay - Absent - Present, Not Voting - Please note: the following statements by legislators do not affect the vote count that was recorded. AJ Louderback: "When Record No. 2324 was taken, I was temporarily out of the house chamber. I would have voted yes." (view other statements of vote for this Rep) J. M. Lozano: "When Record No. 2324 was taken, I was excused because of important business. I would have voted yes." (view other statements of vote for this Rep) Will Metcalf: "When Record No. 2324 was taken, I was presiding in the chair and was shown voting present, not voting. I would have voted yes." (view other statements of vote for this Rep) |
